1,1'-(1,4-phenylenebis(methylene))bis(1,4,8,11-tetraazacyclotetradecane)octahydrochloride dihydrate,
1,1'-(1,4-phenylenebis-(methylene))-bis-1,4,8,11-tetraazacyclotetradecane octahydrochloride dihydrate,
AMD 3100,
AMD 3329,
AMD-3100,
AMD-3329,
AMD3100,
bicyclam,
JM 3100,
JM3100,
mezobil,
mozobil,
plerixafor,
plerixafor hydrochloride,
plerixafor octahydrochloride,
RPA bicyclam,
Plerixafor,
110078-46-1,
Mozobil,
AMD3100,
1,4-Bis((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzene,
bicyclam JM-2987,
plerixafor (amd3100),
Amd 3100,
AMD-3100,
1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane,
JM 3100,
UNII-S915P5499N,
JM-3100,
CHEMBL18442,
JM3100,
1,1'-[1,4-Phenylenebis(methylene)]bis-1,4,8,11-tetraazacyclotetradecane,
S915P5499N,
SID791,
1,1'-[1,4-Phenylenebis(methylene)]bis[1,4,8,11-tetraazacyclotetradecane],
AMD3100 octahydrochloride,
1-{[4-(1,4,8,11-tetraazacyclotetradecan-1-ylmethyl)phenyl]methyl}-1,4,8,11-tetraazacyclotetradecane,
Mozobil (TN),
SDZ SID 791,
Plerixafor [USAN:INN:BAN],
GNA & AMD-3100,
HHA & AMD-3100,
JKL 169,
JM 2987,
Plerixafor(AMD3100),
AC1L22ET,
Plerixafor-d4 (deuterated),
SCHEMBL19038,
GTPL844,
Plerixafor (JAN/USAN/INN),
CTK8C4952,
KS-00000OBY,
AOB5591,
CHEBI:125354,
YIQPUIGJQJDJOS-UHFFFAOYSA-N,
BCPP000104,
BCP02337,
C28H54N8,
EX-A1762,
AN-436,
ANW-73610,
BDBM50035696,
MFCD05662218,
s8030,
ZINC22443609,
1,1'-{1,4-phenylenebis(methylene)}-bis{1,4,8,11-tetraaza-cyclotetradecane},
AKOS005266706,
CS-0451,
DB06809,
JM 3100, AMD3100,
RL00426,
NCGC00165722-01,
NCGC00165722-02,
1,1'-[1,4-Phenylenebis(methylene)]bis[1,4,8,11-tetraazacyclotetradecane] & Galanthus nivalis agglutinin (GNA),
4CA-1029,
AC-26837,
AJ-81365,
AK-41732,
AS-42504,
BC623053,
HY-10046,
SC-21932,
AB0009909,
AB1008451,
LS-187299,
ST2414835,
TC-162355,
FT-0660392,
A25446,
D08971,
S-7677,
AB01566900_01,
078P461,
A809618,
L000104,
SR-01000941593,
I14-9461,
J-503718,
SR-01000941593-1,
11''''-xylyl bis-1,4,8,11-tetraazacyclotetradecane,
BRD-K33240821-367-01-8,
Z2196779619,
1,1''''-{1,4-phenylenebis(methylene)}-bis{1,4,8,11-tetraaza-cyclotetradecane},
1,1'[1,4-phenylene-bis-(methylene)]-bis-1,4,8,11-tetraazacyclotetradecane,
1,1'-[1,4-Phenylenebis(methylene)]bis[1,4,8,11-tetraazacyclotetradecane] & Hippeastrum hybrid agglutinin( HHA),
1,4,8,11-tetraazacyclotetradecanyl[4-(1,4,8,11-tetraazacyclotetradecanylmethyl)phenyl]methane,
1,4,8,11-tetraazacyclotetradecanyl[4-(1,4,8,11-tetraazacyclotetradecanylmethyl)phenyl]methane(8HBr.2H2O),
1-({4-[(1,4,8,11-tetraazacyclotetradecan-1-yl)methyl]phenyl}methyl)-1,4,8,11-tetraazacyclotetradecane,
11-{4-[4,8, 11-1,4,8,11tetraaza-cyclotetradec-1-ylmethyl]-benzyl}-1,4,8,11tetraaza-cyclotetradecane-1,4,8-tricarboxylic acid tri-tert-butyl ester,
Bicyclam,
Plerixafor hcl,
Plerixafor 8HCl,
Plerixafor [USAN],
Plerixafor hydrochloride,
Plerixafor (INN/USAN),
D0L5RW,
Plerixafor Octahydrochloride,
Sid 791,
cc-304,
SDZ-SID-791,
C28H54N8.8ClH,
CHEMBL2311089,
UNII-OD49913540,
C28-H54-N8.8Cl-H,
CID65015,
155148-31-5,
ACN-040171,
Plerixafor, 99% - 100MG 100mg,
A13074,
1,1'-[1,4-Phenylenebisnu(methylene)]bis-1,4,8,11-tetraazacyclotetradecane,
1,1'-(1,4-Phenylenebis(methylene))bis-1,4,8,11-tetraazacyclotetradecane octahydrochloride,
1,4,8,11-Tetraazacyclotetradecane, 1,1'-(1,4-phenylenebis(methylene))bis-,
1,1'-(1,4-Phenylenebis-(methylene))-bis-1,4,8,11-tetraazacyclotetradecane octahydrochloride dihydrate,
1,1'-[1,4-Phenylenebis(methylene)]bis[1,4,8,11-tetraazacyclotetradecane] & Hippeastrum hybrid agglutinin(HHA),
1246819-87-3,